Tom Lynch, Interim Chief Executive Officer

Tom Lynch, a Partner, Senior Managing Director, and Head of the Boston office of SierraConstellation Partners, brings with him over two decades of capital market experience with a deep focus in restructuring, workouts, recapitalizations, M&A, secondary market transactions, as well as strategic planning and execution.

Prior to joining SCP, Tom was the co-founder and Managing Partner of Woods Hole Capital. Tom was responsible for the executive management and strategic direction of the firm. Tom focused on all aspects of the firm including risk management, portfolio management, operations and the executive leadership of the firm.

Prior to founding Woods Hole Capital, Tom was the Chairman and Chief Executive Officer of Frederick’s of Hollywood Group (a publicly traded company). In this capacity, Tom led an out of court financial and operational restructuring which culminated in a sale to Phil Falcone’s HRG Group in 2014. Prior to joining Frederick’s, Tom was the CEO of Mellon HBV later renamed Fursa Alternative Strategies. HBV was a risk arbitrage fund that had moved toward event driven less liquid positions.

Tom has a lengthy and distinguished career in the asset management business. As a Managing Director of Mellon Institutional Asset Management, Tom was a member of the Senior Management Committee, and had direct executive responsibility for a 38 billion AUM business. While at Mellon, Tom founded and launched Mellon’s first Alternative Asset Management distribution group.

Tom has held executive positions with UBS Global Asset Management and the Dreyfus Corporation.

Tom is a graduate of St. Anselm College.

Tim Bossidy, Interim Chief Operating Officer

Zeeshan Hyder, Chief Financial Officer

Zeeshan Hyder brings nearly a decade of experience analyzing and evaluating investment opportunities for large institutions. He was formerly an investment banker at Citigroup where he advised on M&A transactions across the mining, healthcare and consumer industries. Mr. Hyder was also an investment analyst at The Eli and Edythe Broad Foundation's $2 billion investment fund. Most recently Mr. Hyder was a vice president at First Beverage Ventures, a private equity firm focused on emerging food and beverage brands.

Mike Lane , Chief Digital Officer

Mike Lane leads the development of digital products that differentiate and extend the MedMen customer experience both online and in-store. He brings more than 20 years of experience in product development and design at major brands like Live Nation, Ticketmaster, FOX Broadcasting, Adobe, and Accenture. Prior to joining MedMen, Mr. Lane was Vice President of Product at global technology innovator Grindr, the world's largest location-based social network connecting the LGBTQ community.

Dan Edwards, Senior Vice President of Legal Affairs

Dan Edwards oversees MedMen’s legal department and ensures operations adhere strictly to applicable laws and regulations. Mr. Edwards brings extensive experience in corporate law, mergers and acquisitions, intellectual property, commercial real estate, cannabis law and compliance, and he has successfully structured and closed over $500 million in cannabis-related transactions. Prior to joining MedMen, Mr. Edwards worked at San Diego business law firm Potente APLC where he developed and managed the firm's first cannabis division.

Esther Song, Senior Vice President of Marketing and Communications

Esther Song leads the marketing and communications department at MedMen, overseeing marketing’s retail, digital, product, brand and creative teams. With over 15 years of experience in public relations, she has worked to generate visibility in media and consumer relationships through talent partnerships and influencer content for clients including Tod’s and BPCM. Prior to joining MedMen, Ms. Song was Vice President of Public Relations and Partnerships at Tory Burch for nearly a decade.

Felix Popescu, Senior Vice President of Strategic Planning

Felix Popescu oversees MedMen’s strategic planning including interfacing cross-functionally with key stakeholders across the organization to implement strategic initiatives with Human Resources, Insurance, Corporate Optimization, Licensing, and Manufacturing/Distribution among others. He operates with an acute focus on defining MedMen’s strategy and resource allocation to maximize operating leverage and ROI. Mr. Popescu brings nearly ten years of experience advising and executing on mergers and acquisitions. Formerly, he was an investment banker at Lazard and Jefferies. Mr. Popescu also acquired a deep understanding of healthcare services from his time at ProCure, a leader in the radiation oncology space, and most recently at DaVita, one of the largest kidney care providers in the U.S.

Ben Rose, Executive Chairman of the Board

Ben Rose is the chief investment officer for Wicklow Capital, an active early stage investor in a variety of innovative sectors, including blockchain technologies, biotechnology and cannabis. At Wicklow, Ben focuses on working with portfolio investments to identify strategic opportunities for growth while building best in class operations. He has more than 20 years of experience in both financial markets and entrepreneurial finance, having served as a managing director, portfolio manager and trader for a variety of institutional, high performance investment firms.

Niki Christoff, Director

Ms. Christoff currently serves as a Senior Vice President of Strategy and Government Relations at Salesforce, where she has held the role since 2017. Prior to joining Salesforce, Ms. Christoff served as Senior Director of Public Policy at Uber. Ms. Christoff also held a number of positions at Google over a span of eight years, including most recently, serving as Director of Global Communications and Public Affairs. In 2019, Ms. Christoff was named one of Fortune’s “25 Most Powerful Women in Politics”

Mel Elias, Director

Mel Elias is an active investor, entrepreneur and developer in Los Angeles has past and present board experience in CPG and consumer retail businesses both in the US and internationally. He was President and CEO of The Coffee Bean & Tea Leaf for 6 years, until it was sold in 2013.

Chris Ganan, Director

Chris Ganan brings vast institutional experience in business operations, private equity, investment banking, real estate and FinTech. Mr. Ganan was instrumental in MedMen's capital formation and guides MedMen's investment strategy, ensuring MedMen continues to grow its footprint in North America’s most strategic cannabis markets. Previously, Mr. Ganan was managing member of Cratus Equity, a private investment firm. He has also worked for Alvarez & Marsal, CohnReznick, and Investments Limited.

Errol Schweizer, Director

Errol Schweizer is a strategic advisor to several high-growth retailers and brands. Mr. Schweizer has over 25 years of experience in the food and cannabis industries, including 15 years at Whole Foods Market, where he held a number of roles within the organization, including Vice President of Grocery. In this role, Mr. Schweizer oversaw merchandising, product assortment, promotional programs and financial performance for over 80 product categories and $5 billion in annual sales.

Cameron Smith, Director

Cameron Smith currently operates a private angel investment and advisory fund that focuses on health food. Prior to his investment and advisory business, Mr. Smith was General Counsel of The Island ENC, Inc., President of Quantlab Financial and worked at the U.S. Securities Exchange Commission.